EGF Theramed Health Corp.
TMED
CNSX
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -3.85% | 23.97% | 18.07% | 28.34% | -31.58% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -3.85% | 19.60% | 18.07% | 28.34% | -31.58% |
| Operating Income | 3.85% | -19.60% | -18.07% | -28.34% | 31.58% |
| Income Before Tax | -51.88% | -1,735.26% | 4.74% | -420.27% | 44.40% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -51.88% | -2,470.27% | 4.74% | -430.74% | 44.40% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 569.23% | -153.23% | -52.05% | 7,600.00% | -80.60% |
| Net Income | -28.32% | -2,682.74% | -2.53% | -376.85% | 39.35% |
| EBIT | 3.85% | -19.60% | -18.07% | -28.34% | 31.58% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -29.17% | -2,633.33% | 0.00% | -369.23% | 44.19% |
| Normalized Basic EPS | 0.00% | -2,577.42% | -4.17% | -337.50% | 36.00% |
| EPS Diluted | -29.17% | -2,633.33% | 0.00% | -369.23% | 44.19% |
| Normalized Diluted EPS | 0.00% | -2,577.42% | -4.17% | -337.50% | 36.00% |
| Average Basic Shares Outstanding | 0.70% | 1.99% | 1.98% | 1.98% | 8.04% |
| Average Diluted Shares Outstanding | 0.70% | 1.99% | 1.98% | 1.98% | 8.04% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |